Do not assume equipment warranties, service contracts, software, training, or supply access transfer with a med spa sale. Identify each unit and contract, then obtain manufacturer or authorized-provider confirmation for the actual buyer and transaction. Separate asset ownership from ongoing support and budget any approved inspection, enrollment, repair, or transition requirements.
Why is a working device not enough evidence?
A demonstration can show that a device powers on and performs a limited function at a particular moment. It does not prove transferable support, future parts availability, warranty coverage, software rights, or the buyer’s eligibility to obtain supplies. Those questions can materially affect operating continuity and cash.
The seller may accurately say that a device has been serviced while the buyer still lacks the contract or records needed to evaluate future support. A service invoice, a remaining warranty, and a prepaid service plan are different assets. The purchase agreement should identify which rights are included and how their transfer will be established.
Begin with evidence rather than assumptions about a brand. Different products, purchase dates, owners, locations, financing structures, and service histories can produce different terms. A buyer should not describe an entire manufacturer’s equipment as freely transferable or impossible to support from one example agreement.
What does a real manufacturer agreement illustrate?
The Cynosure Lutronic XERF terms of sale provide a concrete example: the published limited warranty is directed to the original purchaser and states that warranties are nontransferable. The agreement also addresses assignment, authorized service, and separate services. These are product-specific published terms, not a universal rule for all devices or every historical contract.
The practical lesson is to obtain the actual agreement and written confirmation for the specific serial number, buyer, and transaction. An equity acquisition may raise different questions from an asset transfer, but the buyer should not infer an answer without reviewing change-of-control and assignment provisions.
Ask the manufacturer to distinguish any remaining warranty from a new service option. A willingness to sell future support does not mean the old warranty transferred. The cost, exclusions, commencement date, inspection requirements, and availability need to be documented separately.
What belongs in the support register?
| Item | Evidence | Decision |
|---|---|---|
| Unit identity | Model, serial, location, photographs | Which asset is covered? |
| Ownership | Invoice, title, financing or lease | Can it transfer? |
| Warranty | Terms, start date, exclusions, claims | Is coverage still effective? |
| Service plan | Contract, payments, renewal, assignment | What support continues? |
| Software and supplies | Licenses and account terms | Can the buyer operate it? |
| Buyer confirmation | Written provider response | What is approved at closing? |
Record accessories and handpieces separately when their coverage differs. A support plan for the main console may not cover consumables or every attachment. Confirm what is included in the sale and whether a replaced component changes the serial-level records.
How should service history be investigated?
Request preventive maintenance, repairs, fault reports, parts replacements, software updates, recalls or field corrections, installation, relocation, and downtime. Reconcile dates, serial numbers, provider identity, and invoices. Investigate gaps without assuming that every missing document proves neglect.
Have a qualified technical reviewer define the inspection scope. The transaction team should understand what was tested, what could not be tested, what records were available, and what future failures remain unpredictable. An inspection is evidence with limits rather than a guarantee of uninterrupted performance.
Ask whether prior repairs, third-party parts, relocation, or unauthorized service affect the actual support terms. Do not make a blanket claim that independent service is always acceptable or always disqualifying. The contract, manufacturer response, technical evidence, and applicable requirements need to be considered together.
How do regulatory status and support differ?
The FDA aesthetic-device resources help identify relevant device categories and regulatory questions. The FDA explanation of registration versus approval warns that establishment registration and device listing do not establish approval, clearance, or authorization.
Those regulatory questions are separate from warranty and service rights. A valid regulatory record does not promise that the buyer can obtain parts, software, training, or warranty coverage. Conversely, a service quote does not establish that every proposed use or operator is permitted.
The buyer should coordinate technical, regulatory, professional, and contract review without expecting one vendor response to answer all four. Establish the actual unit identity and intended services, then route each question to a qualified reviewer. A clean equipment spreadsheet is not a complete clinical operating approval.
What would an illustrative support budget look like?
Assume a fictional buyer must pay $4,500 inspection, $8,000 approved service enrollment, and $6,500 immediate repair. Initial spending is $19,000. Assume a separate $12,000 annual support cost and $9,000 annual capital allowance. These invented amounts are not manufacturer quotes or industry benchmarks.
The $19,000 affects acquisition funding and transition cash. The $12,000 recurring support belongs in the operating budget if not already recorded. The $9,000 capital allowance belongs in a separate cash plan. Do not subtract all three every year from normalized EBITDA or ignore them because depreciation was added back.
Verify whether the seller pays any amount before closing and whether the purchase price already reflects a required repair. The same expense should not appear as a price reduction, seller-paid invoice, and buyer cash use without a reconciliation explaining the distinct effects.
What written confirmation should be requested?
- Identify the exact buyer entity, transaction form, unit, and location.
- Ask whether existing warranty or service rights continue.
- List required consents, inspections, enrollment, and payments.
- Confirm software, supply, training, and account access separately.
- Request effective dates, exclusions, lead times, and quoted terms.
- Preserve the response with the closing evidence and operating plan.
Use an authorized manufacturer or provider channel and verify the responder’s authority. An informal reseller statement may be helpful context but should not substitute for the party controlling the relevant support right. Clarify whether a response is preliminary or a final commitment subject to conditions.
Track quote expiry and appointment availability. A plan that requires a technician visit after closing may leave a gap if the device cannot be used beforehand. The buyer needs to understand that gap’s service, revenue, staffing, and cash consequences.
When should unresolved support change the deal?
Identify how important the device is to current contribution and whether a supported alternative exists. A nonessential asset may be excluded or repriced, while a critical unsupported unit may justify a delay or a different operating plan. The decision should reflect evidence and contractual options, not an automatic rule.
Estimate downtime using actual qualified advice and service availability rather than a convenient number. Consider patient scheduling, refunds, staff capacity, replacement equipment, financing, and permissions. Do not assume the buyer can move every treatment to another unit or provider without review.
Allocate responsibility for open issues and require clear completion evidence. A seller promise to arrange support later can be difficult to enforce operationally even if the agreement provides a financial remedy. The acquisition needs a realistic path to operating on the agreed date.
What should the buyer retain after closing?
Keep the asset schedule, contracts, manufacturer correspondence, inspections, service history, approved access, renewal calendar, and responsibility register together. Update records when equipment moves, parts change, or support renews. Diligence evidence should become a useful operating file rather than disappear into a closing archive.
Use the buyer roadmap, operations hub, valuation guidance, and seller hub. The diligence guide, Four-Number Med Spa Valuation Screen, and offer-to-proceeds bridge connect support evidence to earnings, funding, and cash. The final answer should be specific to the unit and buyer, not a generic assurance that equipment is “under warranty.”
What else do owners and buyers ask?
Does equipment warranty transfer with ownership of the device?
Not automatically. Review the actual warranty, purchaser identity, assignment or change-of-control terms, unit serial number, location, and manufacturer requirements. Obtain written confirmation for the real transaction. Different products and contracts can have different terms, so neither a working demonstration nor a generic brand statement establishes transferable coverage.
Is a service contract the same as a warranty?
No. They can cover different events, periods, components, costs, and responsibilities. A buyer may be able to purchase support without inheriting the original warranty. Review both documents and confirm transfer, exclusions, renewal, authorized service, software, supplies, and effective dates rather than treating every support arrangement as interchangeable coverage.
Does FDA clearance prove the buyer will receive manufacturer support?
No. Regulatory status and commercial support rights are separate questions. Clearance or approval does not establish warranty transfer, software access, parts availability, training, or service pricing. Verify the exact unit and intended use, then obtain the actual contract and manufacturer confirmation while qualified reviewers address regulatory and professional requirements.
Should initial support spending reduce normalized EBITDA?
Separate recurring operating costs from one-time inspection, enrollment, or repair spending and from future capital needs. Verify whether each amount is already recorded or reflected in price. A consistent model shows operating earnings, acquisition funding, and ongoing cash separately, avoiding both omitted costs and duplicate deductions for the same item.
Which sources support this guide?
Sources were checked during research. Regulations, lender policies, and market conditions can change. Use the linked primary material and your advisors to confirm applicability.
- XERF terms and conditions of sale — Cynosure Lutronic
- Aesthetic and cosmetic devices — U.S. Food and Drug Administration
- FDA registration is not device approval, clearance, or authorization — U.S. Food and Drug Administration
Educational analysis prepared with AI-assisted research for The Med Spa Broker. “Last reviewed” records the source and editorial check date; it does not imply review by an attorney, clinician, or independent appraiser. Read our editorial standards.